Bladder cancer following upper tract urothelial carcinoma
- 10 January 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 8 (1) , 75-85
Abstract
Upper tract urothelial carcinoma (UTUC) is uncommon relative to primary bladder transitional cell carcinoma, with notable differences at the genetic, molecular and clinical levels. A variety of management options with similar oncologic outcomes are available for UTUC. Regardless of upper tract treatment modality, recurrence in the bladder consistently occurs in 20-50% of patients, thus presenting a significant clinical challenge. The initial intravesical relapse typically occurs within the first 2 years following upper tract therapy, but the risk is lifelong and repeat episodes are common. The identification of variables that allow accurate risk stratification of UTUC patients with regards to future bladder relapse is crucial. Unfortunately, to date, no variables have been identified that can reliably predict such bladder recurrences. A history of bladder cancer prior to UTUC resection and upper tract tumor multifocality are frequently reported clinical risk factors. Candidate molecular markers, such as E-cadherin, also hold promise for improving patient risk stratification. The impact of bladder recurrences on patient survival is still poorly defined. The risk of progression to invasive bladder disease is not well documented but appears to be an infrequent event. This article highlights important recent observations and key current issues regarding UTUC and subsequent bladder cancer. In addition, we suggest a bladder surveillance regimen following UTUC and provide recommendations for managing patients with intravesical recurrences.Keywords
This publication has 57 references indexed in Scilit:
- Management of patients with upper urinary tract transitional cell carcinomaNature Reviews Endocrinology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Laparoscopic Nephroureterectomy for Upper Tract Transitional Cell Carcinoma: Comparison of Laparoscopic and Open SurgeryEuropean Urology, 2006
- Upper Urinary Tract Cancer: Location is Correlated with PrognosisEuropean Urology, 2005
- Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implicationsInternational Journal of Urology, 2005
- Expression of Hypoxia-Inducible Factor-1α Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary TractClinical Cancer Research, 2005
- Hand Assisted Retroperitoneoscopic Nephroureterectomy: Comparison With the Open ProcedureJournal of Urology, 2003
- RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancerBJU International, 2003
- Diagnostic Accuracy of Ureteroscopic Biopsy in Upper Tract Transitional Cell CarcinomaJournal of Urology, 1997
- Trends in the Incidence of Cancer of the Kidney, Pelvis, Ureter and Bladder in Denmark 1943–88Scandinavian Journal of Urology and Nephrology, 1993